Merck to Present New Data from its HIV Portfolio at the 17th European AIDS Conference
Dateline City:
KENILWORTH, N.J.
Presentations Will Feature Analyses from the Company’s Approved and Investigational HIV Medicines
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new data from its broad HIV portfolio will be presented at the 17th European AIDS Conference (EACS 2019) taking place Nov. 6 – 9, 2019 in Basel, Switzerland.
Language:
English
